Injectable Drug Delivery Market Size, Share, Growth Report 2030

Injectable Drug Delivery Market

Injectable Drug Delivery Market by Type (Formulation and Devices), by Application (Autoimmune Diseases, Oncology Disorders, Hormonal Disorders, Orphan Diseases, and Others), and by End-User (Hospital, Home Care, Ambulatory Care, Physician Offices or Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 05-Mar-2019 Category: Pharmaceutical Report Format : PDF Pages: 120 Report Code: ZMR-213 Status : Published

Global injectable drug delivery market expected to generate around USD 932.3 billion by 2025, at a CAGR of 11.2% between 2019 and 2025. The global injectable drug delivery market is anticipated to grow at a considerable rate over the forecast time period, owing to the growing prevalence of various chronic diseases, such as cancer, heart diseases, diabetes etc.

Injectable Drug Delivery Market

The report covers a forecast and an analysis of the injectable drug delivery market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based revenue (USD Billion). The study includes drivers and restraints of the injectable drug delivery market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the injectable drug delivery market on a global level.

In order to give the users of this report a comprehensive view of the injectable drug delivery market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Injectable Drug Delivery Market1

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new application launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the injectable drug delivery market based on type, application, end-user, and region. By type, the global injectable drugs market includes formulation and devices. The formulation segment is sub-segmented into conventional drug delivery (suspensions, solutions, lyophilized formulations, and emulsions), novel drug delivery (long-acting injection formulation, colloidal dispersions, and microparticles), and others. The devices segment includes conventional injection devices and self-injection devices. The self-injection devices segment is further classified into needle-free injectors (NFI), pen injectors, wearable injectors, auto-injectors, and others. The conventional injection devices are segmented into prefilled syringes, fillable syringes, and others. By application, the global injectable drug delivery market is segmented into autoimmune diseases, oncology disorders, hormonal disorders, orphan diseases, and others. By end-user, this global market includes home care, hospital, ambulatory care, physician offices or clinics, and others. By geography, the global injectable drug delivery market includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa with its further division into major countries, such as the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa.

Some key players of the global injectable drug delivery market are Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG., Schott AG, and Eli Lily & Company.

Report Scope:

Report Attribute Details
Base Year 2022
Historic Years 2018 - 2022
Forecast Years 2023 - 2030
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2023 to 2030
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

This report segments the global injectable drug delivery market into:

Global Injectable Drug Delivery Market: Type Analysis

  • Formulation
    • Conventional Drug Delivery
      • Suspensions
      • Solutions
      • Lyophilized Formulations
      • Emulsions
    • Novel Drug Delivery
      • Long Acting Injection Formulation
      • Microparticles
      • Colloidal Dispersions
    • Others
  • Devices
    • Self-Injection Devices
      • Needle-Free Injectors (NFI)
      • Wearable Injectors
      • Pen Injectors
      • Auto-Injectors
      • Others 
    • Conventional Injection Devices
      • Prefilled Syringes
      • Fillable Syringes
      • Others

Global Injectable Drug Delivery Market: Application Analysis

  • Autoimmune Diseases
  • Oncology Disorders
  • Hormonal Disorders
  • Orphan Diseases
  • Others

Global Injectable Drug Delivery Market: End-User Analysis

  • Home Care
  • Hospital
  • Ambulatory Care
  • Physician Offices or Clinics
  • Others

Global Injectable Drug Delivery Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

Methodology

Free Analysis

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed